Cure Rates of Superficial Basal Cell Carcinoma Following 1 Versus 3 Cycles of Electrodessication & Curettage: A Randomized Prospective Study
Phase 4
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Superficial Basal Cell Carcinoma
Both
Superficial Basal Cell Carcinoma
Trial Information
Cure Rates of Superficial Basal Cell Carcinoma Following 1 Versus 3 Cycles of Electrodessication & Curettage: A Randomized Prospective Study
Inclusion Criteria:
- Untreated, biopsy proven superficial type basal cell carcinoma (BCC-S) on the trunk
and/or extremities
- Age greater than 21
- Women with childbearing potential (including those who are pregnant/lactating)
- Able to provide written informed consent
Exclusion Criteria:
- Aggressive histology on initial biopsy (i.e. morpheaform, infiltrative, desmoplastic,
or purely micronodular)
- Prior history of BCC or other skin cancer at the same location
- Lesion > 2 cm
- Patients with basal cell nevus syndrome
- Transplant patients
- Immunocompromised patients
- Recurrent BCC
- Greater than 2 BCC-S on the trunk and/or extremities
- Prisoners
- Allergy to lidocaine or epinephrine
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The primary goal of the study is to determine whether there is a difference in cure rates of superficial BCC following one cycle of ED&C versus three cycles of ED&C.
Outcome Time Frame:
base line, every 3 months until 12 month completion
Safety Issue:
No
Principal Investigator
Joyce Teng, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Wisconsin, Madison
Authority:
United States: Institutional Review Board
Study ID:
H-2007-0252
NCT ID:
NCT00994240
Start Date:
May 2008
Completion Date:
Related Keywords:
- Superficial Basal Cell Carcinoma
- Carcinoma
- Carcinoma, Basal Cell
Name | Location |
|---|---|
| University of Wisconsin-Madison, Department of Dermatology | Madison, Wisconsin 53715 |
